Transfer Factor as an Option for Managing the COVID-19 Pandemic
D. VIZA1*, G. PIZZA2*, C. DE VINCI2**, G. BRANDI3 , D. ABLASHI4
1-Immunobiology Laboratory, Faculté de Médicine, Paris 6, France
2- Immunotherapy dept., S. Orsola-Malpighi University Hospital, Bologna, Italy
3- Medical Oncology, S. Orsola-Malpighi University Hospital, Bologna, Italy
4- HHV-6 Foundation, Santa Barbara, CA, USA * fmr Director, **fmr Assistant
file:///C:/Users/E459~1/AppData/Local/Temp/TF-antiCovid%20cikk%20english%205old.pdf
Folia Biologica (Praha) 66, 86-90 (2020)
(cell-mediated immunity / Covid-19 / cytotoxic T lymphocytes / flu / herpes / immunodeficiencies / immunomodulation / transfer factor / vaccines / T cells)
